Extracorporeal Membrane Oxygenation System Market, by Modality (Arteriovenous, Venoarterial and Venovenous), by Application (Extracorporeal Cardiopulmonary Resuscitation, Cardiac and Respiratory), by Age Group (Neonatal, Pediatric and Adult), and by Geography - Global Forecast to 2026

  • Published On : May 2018 |
  • Pages : 170 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Extracorporeal Membrane Oxygenation (ECMO) System Market Insights

Extracorporeal membrane oxygenation system is a life supporting system providing cardiac and respiratory support to the patients suffering from severe respiratory failure. ECMO circuit comprises cannulas, pump, blender and oxygenator, which oxygenates the blood and remove carbon dioxide through extracorporeal gas exchange device referred as membrane oxygenator. The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. Potential indications for which ECMO is used includes severe acute respiratory distress syndrome (ARDS), acute hypercapnic respiratory failure, to bridge lung transplantation, primary graft dysfunction post-lung transplantation, and pulmonary hypertension with right ventricular failure.

The global ECMO system market was valued at US$ 248.2 million in 2017, and is expected to witness a CAGR of 5.3 % over the forecast period (2018 – 2026).

Figure 2. Global Extracorporeal Membrane Oxygenation System Market, By Modality

extracorporeal membrane oxygenation system market

Source: Coherent Market Insights Analysis (2018)

Increasing Number of Cardiac and Respiratory Disease are Propelling Growth of the Extracorporeal Membrane Oxygenation System Market

Increasing incidence of cardiovascular and respiratory disorders are the major factor driving growth of the ECMO system market. According to World Health Organization (WHO), around 17.7 million people died from cardiovascular disease in 2015, representing 31% of total global deaths.  Moreover, according to European Respiratory Society, Chronic Obstructive Pulmonary Disease (COPD) affects more than 200 million people and is the fourth leading cause of death in the world. Furthermore, according to European Heart Network AISBL, cardiovascular disease causes 3.9 million deaths every year in Europe and over 1.8 million in European Union, accounting of 45% and 37% of all deaths, respectively. Increasing number of organ transplant surgeries is expected to drive growth of the ECMO system market over the forecast period (2017 - 2025). For instance, according to Organ and Tissue Authority of Australian Government, the number of surgeries performed for organ transplant in 2017 were around1, 469. Moreover, around 1,400 Australians are waiting for organ transplant.

Increasing disease prevalence will led to increasing demand for extracorporeal membrane oxygenation system in hospitals and surgical centers. According to annual international registry by Extracorporeal Life Support Organization (ELSO), 65,171 patients received ECMO system in 2015, increased to 98,840 in 2018 among which 40,256 are neonatal, 22,952 are pediatric, and 35,632 adult.

On the basis of region, extracorporeal oxygenation system market is segmented into North America, Latin America, Europe, Africa, Asia Pacific, and Middle East. North America is leading the ECMO system market, owing to various factors such as well-established healthcare infrastructure, government funds, and reimbursement framework. Moreover, high pool of Chronic Obstructive Pulmonary Disease (COPD) and other disorders are expected to fuel market growth in this region. Furthermore, around 85 million and 49 million people were suffering from cardiovascular disease in Europe and European Union, respectively in 2015. According to Centers for Disease Control and Prevention (CDC), COPD was the third leading cause of death with more than 15 million Americans diagnosed with COPD every year in 2011. Furthermore, Asia Pacific region is expected to gain significant traction in ECMO system market, attributed by advancements in healthcare system with support of government initiatives.

Industrial Collaboration by the Key Players is Fueling Extracorporeal Membrane Oxygenation System Market

The global extracorporeal membrane oxygenation system market is operated by Medtronic Plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation and Alung technologies Inc. The industry players are adopting the strategy of collaboration focusing on development of new products. For instance, in 2018, Medtronic Plc. collaborated with the Sayler Biomedical LLC, for the development of their product Century heart Lung machine. The collaboration has made the Medtronic’s product available for customers globally. Century heart lung machine has features, such as compact and sturdy design, easy to use components and affordable price. This is expected to strengthen customer base and widen the product portfolio of Medtronic.

Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are 3 different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial and venovenous whereas on the bases of age, it is classified into neonatal, pediatric and adult. The growing number of congenital heart defects, increase the demand for ECMO. For instance, according to American Heart Association, approximately 40,000 babies are born with a congenital heart defect in United States each year and around 2 to 3 million individuals are living with a congenital heart defect.

Market Dynamics

The growth of ECMO market is due to factors like increasing prevalence of cardiovascular and chronic respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, in 2014, Centers for Disease Control and Prevention (CDC) reported 1,417,101 deaths globally due to chronic respiratory disease. Moreover, increasing implementation of ECMO will also swell the ECMO system market. According to National Center for Biotechnology Information, ECMO is effective and growing means of life support for the patients with swine flu infection by bridging the gap, between respiratory distress to total body recovery. Further, medical policies such as Premera, supports extracorporeal membrane oxygenation (ECMO) in adults may be considered medically necessary for the management of acute respiratory failure. On the flip side of the coin, the ECMO system market is expected to be hampered by the complications associated with the ECMO system such as internal bleeding, blood clotting or technical failure.

Key features of the study:

  • This report provides in-depth analysis of the extracorporeal membrane oxygenation system market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global extracorporeal membrane oxygenation (ECMO) system market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Medtronic plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation, Alung technologies Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
  • The global extracorporeal membrane oxygenation (ECMO) system market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for extracorporeal membrane oxygenation system market, research and consulting firms, new entrants and financial analysts

Detailed Segmentation:

  • Global Extracorporeal Membrane Oxygenation System Market, By Modality:
    • Arteriovenous
    • Venoarteial
    • Venovenous
  • Global Extracorporeal Membrane Oxygenation System Market, By Application:
    • Extracorporeal cardiopulmonary resuscitation
    • Cardiac
    • Respiratory
  • Global Extracorporeal Membrane Oxygenation System Market, By Age Group:
    • Neonatal
    • Pediatric
    • Adults
  • Global Extracorporeal Membrane Oxygenation System Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Europe
      • By Country
        • Germany
        • UK
        • France
        • Spain
        • Russia
        • Rest of Europe
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Asia-Pacific
      • By Country
        • China
        • India
        • South Korea
        • Japan
        • Australia
        • ASEAN
    • Rest of Asia-Pacific
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Africa
      • By Country
        • North Africa
        • Central Africa
        • South Africa
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
  • Company Profiles
    • Medtronic plc. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments
      • Strategies
    • Getinge Group
    • LivaNova Plc.
    • Terumo Corporation
    • Xenios AG
    • Microsoft Scientific Co.
    • Origen Biomedical
    • Eurosets S.R.L.
    • Nipro Corporation
    • Alung technologies Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Modality
      • Market Snippet, By Application
      • Market Snippet, By Age Group
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements
    • Industry Trends
    • PEST Analysis
    • PORTER’S Five Forces
  4. Global Extracorporeal Membrane Oxygenation System Market, By Modality, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Arteriovenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Venoarteial
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Venovenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Extracorporeal Membrane Oxygenation System Market, By Application, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Extracorporeal cardiopulmonary resuscitation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Cardiac
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Respiratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Extracorporeal Membrane Oxygenation System Market, By Age Group, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Neonatal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Extracorporeal Membrane Oxygenation System Market, By Region, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Region, 2016 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Argentina
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Medtronic Plc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Getinge Group
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • LivaNova Plc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Terumo Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Xenios AG
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Microsoft Scientific Co.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Origen Biomedical
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Eurosets S.R.L.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Nipro Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Alung technologies Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
  9. Section
    • References
    • Analyst Views
    • Research Methodology
    • About Us and Sales Contact

*Browse 36 market data tables and 32 figures on "Extracorporeal Membrane Oxygenation System Market - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.